Australian company, Minomic, could be a force of change in prostate cancer diagnosis. The biotechnology company has been developing and testing a more accurate blood test for the diagnosis of prostate cancer, which could reduce the chance of “false positive” results and improve the accuracy of testing for prostate cancer. The new test, which recently … Continue reading A Revolution in the Testing for Prostate Cancer?